Volume 4, Issue 3
Editorialp. 239
Methotrexate in rheumatoid arthritis: experience and recommendations from the 3E initiative
Author(s): K Visser, D van der Heijde & M Dougados
Editorialp. 245
Influence of gender on the symptoms and severity of rheumatoid arthritis: do women suffer more?
Author(s): T Sokka
Brief Reportp. 250
Anakinra demonstrates a modest benefit for treating rheumatoid arthritis.
Author(s): Bulletin Board
Brief Reportp. 251
US FDA approves golimumab for treating three types of immune-related arthritis
Author(s): Bulletin Board
Brief Reportp. 251
Neurotransmitter receptor may modulate inflammation in RA synovium
Author(s): Bulletin Board
Discussion Paperp. 253
Certolizumab pegol for rheumatoid arthritis: effective in combination with methotrexate or as monotherapy
Author(s): PJ Mease
Book Reviewp. 267
Risk factors for thrombotic events in patients with systemic lupus erythematosus from different ethnic groups
Author(s): GS Alarcon
Review Articlep. 271
Biomarkers in Beh�§etâ��s disease: diagnosis and disease activity
Author(s): J Nowatzky & T Chajek-Shaul
Review Articlep. 287
Which autoantibodies announce that lupus nephritis is on the way?
Author(s): D Cornec, E Cornec-Le Gall, Z Segalen, C Hanrotel-Saliou, Y Le Meur, Y Renaudineau & P Youinou
Review Articlep. 297
Vitamin D in systemic lupus erythematosus: potential beyond bone health
Author(s): JA Reynolds & IN Bruce
Review Articlep. 321
Salivary gland imaging techniques for the diagnosis of Sj�¶grenâ��s syndrome
Author(s): AG Tzioufas & HM Moutsopoulos
Review Articlep. 343
Fibromyalgia treatment: the role of exercise and physical activity
Author(s): AJ Busch, TJ Overend & CL Schachter
